SEC Form 4/A · accession 0001209191-19-003178
Nightstar Therapeutics plc · NITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Tuyen Ong
Officer — Chief Development Officer
Period of report
Jan 3, 2019
Accepted (ET)
Jan 9, 2019 · 9:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711675
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F3 | Jan 3, 2019 | S | 4,070 | $12.00 | D | 85,471 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- F3The original Form 4 has been amended to include all unvested restricted shares disclosed in the Reporting Person's Form 3 in Column 5 of this Form 4/A. This Form 4/A amends and restates, in its entirety, the original Form 4.